设为首页 加入收藏

TOP

GATTEX (teduglutide [rDNA origin]), for injection(二十)
2016-06-14 08:43:02 来源: 作者: 【 】 浏览:8030次 评论:0
teduglutide injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68875-0101
Route of Administration SUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
teduglutide (UNII: 7M19191IKG) (teduglutide - UNII:7M19191IKG) teduglutide 5 mg  in 0.5 mL
Inactive Ingredients
Ingredient Name Strength
Histidine (UNII: 4QD397987E) 3.88 mg  in 0.5 mL
mannitol (UNII: 3OWL53L36A) 15 mg  in 0.5 mL
sodium phosphate, monobasic, monohydrate (UNII: 593YOG76RN) 0.644 mg  in 0.5 mL
sodium phosphate, dibasic, heptahydrate (UNII: 70WT22SF4B) 3.434 mg  in 0.5 mL
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:68875-0101-2 30 in 1 CARTON 12/21/2012 
1 NDC:68875-0101-1 0.5 mL in 1 VIAL; Type 1: Convenience Kit of Co-Package  
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA203441 12/21/2012 
GATTEX 
teduglutide kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68875-0103
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:68875-0103-1 1 in 1 CARTON 12/21/2012 
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 VIAL 0.5 mL
Part 2 1 SYRINGE, PLASTIC 0.5 mL
Part 3 4 PACKET 2.8 mL
Part 1 of 3
GATTEX 
teduglutide injection, powder, lyophilized, for solution
Product Information
Item Code (Source) NDC:68875-0101
Route of Administration SUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
teduglutide (UNII: 7M19191IKG) (teduglutide - UNII:7M19191IKG) teduglutide 5 mg  in 0.5 mL
Inactive Ingredients
Ingredient Name Strength
histidine (UNII: 4QD397987E) 3.88 mg  in 0.5 mL
mannitol (UNII: 3OWL53L36A) 15 mg  in 0.5 mL
sodium phosphate, monobasic, monohydrate (UNII: 593YOG76RN) 0.644 mg  in 0.5 mL
sodium phosphate, dibasic, heptahydrate (UNII: 70WT22SF4B) 3.434 mg  in 0.5 mL
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:68875-0101-1 0.5 mL in 1 VIAL; Type 1: Convenience Kit of Co-Package  
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA203441 12/21/2012 
Part 2 of 3
WATER 
sterile water liquid
Product Information
Route of Administration SUBCUTANEOUS
Inactive Ingredients
Ingredient Name Strength
water (UNII: 059QF0KO0R) 0.5 mL  in 0.5 mL
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1  0.5 mL in 1 SYRINGE, PLASTIC; Type 1: Convenience Kit of Co-Package  
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA203441 12/21/2012 
Part 3 of 3
PDI ALCOHOL PREP PAD STERILE 
alcohol swab
Product Information
Route of Administration TOPICAL
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
alcohol (UNII: 3K9958V90M) (alcohol - UNII:3K9958V90M) alcohol 0.7 mL  in 1 mL
Inactive Ingredients
Ingredient Name Strength
water (UNII: 059QF0KO0R) 0
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 17 18 19 20 21 下一页 尾页 20/21/21
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇AMARYL(GLIMEPIRIDE tablets) 下一篇Tivicay(Doutegravir 50mg Tablet..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位